Daito Pharmaceutical Co.,Ltd. (4577.T) JPX

Currency In JPY

AD

Valuation

Market Cap34.21B
Enterprise Value42.55B
P/E Ratio12.1
PEG Ratio0.18
Price/Sales Ratio0.75
Price/Book Ratio0.71
Enterprise/Revenue0.89
Enterprise/EBITDA6.23

Fiscal Year

Fiscal YearMay 31, 2026
Most Recent QuarterAugust 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue50.65B
Revenue/Share1,742.82
Gross Profit9.9B
EBITDA8.02B
Net Income3.16B
Diluted EPS107.46

Balance Sheet

Total Cash1.69B
Total Cash/Share59.36
Total Debt8.45B
Total Debt/Equity0.16
Current Ratio2.64
Book Value Per Share1,846.72

Price History

52-Week Change5.28
52-Week High1,521
52-Week Low1,120
Moving Average 50 Days1,318.4
Moving Average 200 Days1,316.98

Statistics

Average Volume84,888
Shares Outstanding28.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate40
Trailing Annual Dividend Yield3.04
Payout Ratio0.35
Last Split Factor2:1
Last Split DateMay 29, 2025
AD